Cooper Companies Inc (COO)

NASDAQ
Currency in USD
Disclaimer
341.08
+4.16(+1.23%)
Closed
After Hours
341.080.00(0.00%)
Earnings results expected in 4 days
Day's Range
333.93341.49
52 wk Range
303.74399.62
Prev. Close
336.92
Open
336.61
Day's Range
333.93-341.49
52 wk Range
303.74-399.62
Volume
181,590
Average Vol. (3m)
293,713
1-Year Change
4.43%
Shares Outstanding
49,524,149
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
392.41
Upside +15.05%

People Also Watch

248.00
AJG
-0.40%
441.25
IT
+1.47%
203.39
STE
+1.22%
217.77
VRSN
+2.62%
How do you feel today about COO?
Vote to see community's results!
or

Cooper Companies Inc Company Profile

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women’s health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.